About us

Bionova Capital is an independent, healthcare-focused venture capital firm, investing in early-stage life science companies. It was founded in 2015 by the shareholders of Hovione, one of the largest pharmaceutical company in Portugal, with manufacturing and research operations in USA, Ireland, China and Portugal. Bionova Capital was formerly known as Hovione Capital.

Our team has deep expertise in company building and drug development, and a track record investing in therapeutics, medtech and digital health.

We invest in Europe, looking for opportunities in academia, biotech, and pharmaceutical companies. 
 
We collaborate with exceptional entrepreneurs and provide capital, expertise and access to a global network of resources to add operational, strategic and financial value. We capitalize on our shareholders’ experience, who have successfully built a 60-year-old, profitable business in the global pharmaceutical industry.

Before investing in a company, we perform a rigorous and extensive due diligence process and help entrepreneurs improve their product development roadmap.



Bionova Capital is a venture capital company supervised and regulated by the Portuguese Securities Market Commission (CMVM).

Your cookie settings

We ask you to accept cookies for the purpose of performance, social networking and advertising.
For more information or correct your preferences, press the button "more info".
For more information about these cookies and the processing of your personal data, check out our cookie and Privacy Policy. Accept these cookies and the processing of personal data involved?

Accept cookies More information